{
    "type": "ETP",
    "ucits": false,
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "replication_method": "synthetic",
    "complex_factors": [
        "Leverage",
        "Synthetic replication via swaps",
        "Counterparty risk",
        "Collateralized swap exposure",
        "Daily leverage reset and compounding effect",
        "Opaque payoff structure"
    ],
    "classification": "complex",
    "supporting_data": "The product is a 3x leveraged daily ETP seeking to replicate 3 times the daily performance of Diageo plc via a swap with Natixis as the swap provider. It uses synthetic replication through a collateralized swap, introducing counterparty and collateral risks. The leverage is significant (3x), with daily reset causing compounding effects that make returns over periods longer than one day deviate from simple multiples of the underlying asset's performance. The product is explicitly described as high risk (risk class 7/7) and is intended for investors with specific knowledge and experience, indicating complexity. The use of swaps as the core replication method, the embedded leverage, and the complex payoff profile with daily resetting leverage and compounding effects make the product complex under MiFID II criteria. According to MiFID II Article 25(4)(a)(vi) and Article 57, instruments embedding derivatives integral to the strategy and with leverage are complex. The product is not UCITS compliant but an ETP. The presence of collateralized swaps and counterparty risk further supports complexity classification. Therefore, the product fails the non-complex criteria of Article 57, including exclusion from derivatives (Art 4(1)(44)(c) and Annex I Section C points 4-11), no excess liability, and ease of understanding. This aligns with ESMA guidance that synthetic ETFs and leveraged products are complex and require appropriateness assessments."
}